All AbMole products are for research use only, cannot be used for human consumption.
Indapamide is a non-thiazide sulphonamide diuretic compound, generally used in the treatment of hypertension, as well as decompensated cardiac failure. Indapamide helps prevent your body from absorbing too much salt, which can cause fluid retention. Indapamide treats fluid retention (edema) in people with congestive heart failure.
 |
Source | J Pharmacol Exp Ther (2008). Figure 5. Indapamide |
| Method | BM-MNC Differentiation into EPCs. | |
| Cell Lines | normotensive Wistar Kyoto (WKY) rats | |
| Concentrations | 10 μM | |
| Incubation Time | 7 d | |
| Results | It is noteworthy that treatment with perindopril, indapamide, or both increased the number of cells double positive for both AcDil-LDL and BS-1 lectin by 1.7-, 1.4-, and 2.0-fold, (p 0.01), respectively, in ischemic SHRs in reference to untreated ischemic SHRs |
 |
Source | J Pharmacol Exp Ther (2008). Figure 3. Indapamide |
| Method | Western Blot | |
| Cell Lines | normotensive Wistar Kyoto (WKY) rats | |
| Concentrations | 10 μM | |
| Incubation Time | 7 d | |
| Results | It is interesting to note that coadministration of perindopril and indapamide markedly increased VEGF protein expression in ischemic SHRs in reference to untreated ischemic SHRs |
| Cell Experiment | |
|---|---|
| Cell lines | Rat A10 vascular smooth muscle cells |
| Preparation method | The cultures were then incubated in DMEM with 10% foetal calf serum, containing vehicle alone or various concentrations of indapamide Ž10y6 ,10y5, 5=10y5 and 5=10y4 . for 16 h, then for 2 h in the same medium containing BrdU Ž10y5 M.. |
| Concentrations | 1, 10, 50, 500 μM |
| Incubation time | 16 h |
| Animal Experiment | |
|---|---|
| Animal models | |
| Formulation | |
| Dosages | |
| Administration | |
| Molecular Weight | 365.83 |
| Formula | C16H16ClN3O3S |
| CAS Number | 26807-65-8 |
| Solubility (25°C) | DMSO 63 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Potassium Channel Products |
|---|
| VU0810464
VU0810464 is a potent and selective non-ureaG protein-gated inwardly-rectifying potassium channels (GIRK, Kir3) activator. VU0810464 displays nanomolar potency for neuronal (EC50=165 nM) and GIRK1/4 (EC50=720 nM) channels with improved brain penetration. |
| QO 58
QO 58 is a potent modulator of K(v)7 channels. |
| NS3623
NS3623 is an activator of human ether-a-go-go-related gene (hERG1/KV11.1) potassium channels. |
| ML67-33
ML67-33 is a selective activator of temperature- and mechano-sensitive K2P channels. |
| A-935142
A-935142 is a human ether-a-go-go-related gene (hERG, Kv 11.1) channel activator. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
